Title
Category
Credits
Event date
Cost
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.50 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Lori Ramkissoon, PhD will review advancements in molecular oncology and demonstrate how this integration of this testing has advanced treatment strategies and improved patient outcomes for diverse cancer types.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.50 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jacob Stein, MD, MPH, reviews several of the most common medical emergencies that arise when caring for patients with cancer. We highlight key aspects of presentation, diagnosis and management, with pearls for clinicians along the way.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.50 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In this webinar, Jared Lowe, MD, HMDC dicusses serious illness and discuss strategies to support patients with a primary focus on reviewing the services of palliative care and hospice care.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Puneet Singh Jolly, MD, PhD discusses keratinocyte neoplasms are by far the most common malignancy in the world. While surgical treatments remain the most common and most effective therapy, there are numerous emerging non-surgical techniques. We discuss these and the rationale for using such treatments, particularly in specific challenging clinical scenarios.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
William Wood, MD, MPH will review ways to expand traditional clinic-based cancer navigation to population-based cancer navigation using a central navigation approach. We will discuss how this approach can foster equity in care delivery and outcomes, while incorporating new initiatives that promote quality improvement. We will also talk about how this work fits into the current national environment that surrounds cancer navigation, including the recent development of a learning community and of new proposed billing codes that support the delivery of navigation services.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Sonali Acharya, PharmD. will explain the role of specialty pharmacies. We will discuss accreditation requirements for specialty pharmacies, process to determine which medications are considered specialty and specifically the benefits of a healthcare system specialty pharmacy.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Dr. Nakamura will present on key topics related to cognitive issues experienced by patients with cancer.
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Radiation therapy is an integral part of cancer treatment across many disease sites, but the locoregional control benefits must be weighed against the potential toxicities. During this webinar, Kevin Pearlstein, MD, will review the role of radiation in cancer care including basic radiobiologic principles, logistics, and toxicities. He will discuss several recent studies examining the omission of radiation for different solid malignancies and review strategies to identify patients who will benefit the most from radiation.
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.25 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Michael Galgano, MD, FAANS, will focus on differentiating the various types of spinal tumors, ranging from metastases, to primary vertebral column tumors, and intradural spinal cord tumors. He will discus the contributions of co-morbidities and frailty on the management of patients with spinal tumors. He will also aim to give the audience a brief exposure to the surgical management of spinal oncology, and what is entailed to execute robust local control.
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.50 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Frances Collichio, MD, reviews the common and uncommon side effects of immune check point inhibitors. She also discusses the relatively new concept of delayed immune related events.

Pages